Characterization of a cascade of protein interactions initiated at the IL-1 receptor

Biochemical and Biophysical Research Communications

Volumn 303, Issue 2, 2003, Pages 525-531

  Boch, Jason A ^a,b   Yoshida, Yasuhiro ^a,b   Koyama, Yoshinobu ^c   Wara Aswapati, Nawarat ^d   Peng, Hiabing ^a,b   Unlu, Sebnem ^a,b   Auron, Philip E ^a,b,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Matsubara Mayflower Hospital   (Japan)

^d KHON KAEN UNIVERSITY   (Thailand)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

IL 1; Interaction; IRAK; IRAK2; MyD88; Receptor; Signal transduction; TRAF6

Indexed keywords

INTERLEUKIN 1 RECEPTOR; PROTEIN; PROTEIN IRAK2; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 0037418693     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00385-1     Document Type: Article

References (22)

1. Dinarello C. Biological basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
2. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:2001;675-680.
3. Auron P. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev. 9:1998;221-237.
4. Vigers G., Anderson L., Caffes P., Brandhuber B. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1β Nature (London). 386:1997;190-194.
5. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley J., Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature (London). 408:2000;111-115.
6. Wesche H., Henzel W., Shillinglaw W., Li S., Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 7:1997;837-847.
7. Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.-L., Di Marco F., French L., Tschopp J. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273:1998;12203-12209.
8. Li S., Strelow A., Fontana E.J., Wesche H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA. 99:2002;5567-5572.
9. Suzuki N., Suzuki S., Duncan G.S., Millar D.G., Wada T., Mirtsos C., Takada H., Wakeham A., Itie A., Li S., Penninger J.M., Wesche H., Ohashi P.S., Mak T.W., Yeh W.C. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature (London). 416:2002;750-756.
10. Shen B., Manley J.L. Phosphorylation modulates direct interactions between the Toll receptor, Pelle kinase and Tube. Development. 125:1998;4719-4728.
11. Burns K., Clatworthy J., Martin L., Martinon F., Plumpton C., Maschera B., Lewis A., Ray K., Tschopp J., Volpe F. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2:2000;346-351.
12. Ye H., Arron J.R., Lamothe B., Cirilli M., Kobayashi T., Shevde N.K., Segal D., Dzivenu O.K., Vologodskaia M., Yim M., Du K., Singh S., Pike J.W., Darnay B.G., Choi Y., Wu H. Distinct molecular mechanism for initiating TRAF6 signalling. Nature (London). 418:2002;443-447.
13. Jiang Z., Ninomiya-Tsuji J., Qian Y., Matsumoto K., Li X. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell. Biol. 22:2002;7158-7167.
14. Marmiroli S., Bavelloni A., Faenza I., Sirri A., Ognibene A., Cenni V., Tsukada J., Koyama Y., Ruzzene M., Ferri A., Auron P.E., Toker A., Maraldi N.M. Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. FEBS Lett. 438:1998;49-54.
15. Wara-aswapati N., Yang Z., Waterman W.R., Koyama Y., Tetradis S., Choy B.K., Webb A.C., Auron P.E. Cytomegalovirus IE2 protein stimulates interleukin 1β gene transcription via tethering to Spi-1/PU.1. Mol. Cell. Biol. 19:1999;6803-6814.
16. Wesche H., Goa X., Li X., Kirschning C., Stark G., Cao Z. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J. Biol. Chem. 274:1999;19403-19410.
17. Muzio M., Ni J., Feng P., Dixit V. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 278:1997;1612-1615.
18. Darnay B., Ni J., Moore P., Aggarwal B. Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB-inducing kinase. Identification of a novel TRAF6 interaction motif. J. Biol. Chem. 274:1999;7724-7731.
19. Pullen S., Dang T., Crute J., Kehry M. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). J. Biol. Chem. 274:1999;14246-14254.
20. Janssens S., Burns K., Tschopp J., Beyaert R. Regulation of interleukin-1- and lipopolysaccharide-induced NF-κB activation by alternative splicing of MyD88. Curr. Biol. 12:2002;467-471.
21. Xiao T., Towb P., Wasserman S., Sprang S. Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell. 99:1999;545-555.
22. Mezhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C.A. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell. 2:1988;253-258.